Literature DB >> 15975276

[Relationship between DLC-1 expressions and metastasis in hepatocellular carcinoma].

Li-jie Song1, Sheng-long Ye, Kai-feng Wang, Yong-qiang Weng, Chun-min Liang, Rui-xia Sun, Yan Zhao, Yin-kun Liu, Zhao-you Tang.   

Abstract

OBJECTIVES: To study the relationship between the expression level of DLC-1 mRNA (located in 8p) and the invasion/metastasis of human hepatocellular carcinoma (HCC).
METHODS: Fifty-one surgical specimens of human HCC were divided into high-invasive and low invasive groups according to their clinicopathological features. DLC-1 mRNA expression was studied in the 51 HCC specimens as well as 5 different metastasis potential cell lines using real-time quantitative PCR (RQ-PCR).
RESULTS: The expression level of DLC-1 mRNA in HCC specimens with high invasiveness was significantly lower than that with low invasiveness (P < 0.05). The expression levels of DLC-1 mRNA were significantly different between non-metastatic (Hep3B and HepG2) and metastatic (MHCC97-H, MHCC97-L and HCCLM3) cell lines (P < 0.05). From MHCC97-L to HCCLM3, with an increase of invasiveness and metastatic potentials, the expression level of DLC-1 decreased correspondingly, and its expression level in HCCLM3 was significantly lower than that in MHCC97-L (P < 0.01).
CONCLUSION: The expression of DLC-1 mRNA may play an important role in inhibiting the invasiveness and metastasis of HCC.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15975276

Source DB:  PubMed          Journal:  Zhonghua Gan Zang Bing Za Zhi        ISSN: 1007-3418


  6 in total

1.  DLC1 suppresses distant dissemination of human hepatocellular carcinoma cells in nude mice through reduction of RhoA GTPase activity, actin cytoskeletal disruption and down-regulation of genes involved in metastasis.

Authors:  Xiaoling Zhou; Drazen B Zimonjic; Sang-Won Park; Xu-Yu Yang; Marian E Durkin; Nicholas C Popescu
Journal:  Int J Oncol       Date:  2008-06       Impact factor: 5.650

Review 2.  Deleted in liver cancer-1 (DLC1): an emerging metastasis suppressor gene.

Authors:  Nicholas C Popescu; Steve Goodison
Journal:  Mol Diagn Ther       Date:  2014-06       Impact factor: 4.074

3.  Genetic and epigenetic silencing of SCARA5 may contribute to human hepatocellular carcinoma by activating FAK signaling.

Authors:  Jian Huang; Da-Li Zheng; Feng-Song Qin; Na Cheng; Hui Chen; Bing-Bing Wan; Yu-Ping Wang; Hua-Sheng Xiao; Ze-Guang Han
Journal:  J Clin Invest       Date:  2009-12-14       Impact factor: 14.808

4.  The role of Dlc1 isoform 2 in K-Ras2(G12D) induced thymic cancer.

Authors:  Mohammad Golam Sabbir; Heather Prieditis; Esther Ravinsky; Michael R A Mowat
Journal:  PLoS One       Date:  2012-07-05       Impact factor: 3.240

5.  Deleted in liver cancer 1 (DLC1) negatively regulates Rho/ROCK/MLC pathway in hepatocellular carcinoma.

Authors:  Carmen Chak-Lui Wong; Chun-Ming Wong; Frankie Chi-Fat Ko; Lo-Kong Chan; Yick-Pang Ching; Judy Wai-Ping Yam; Irene Oi-lin Ng
Journal:  PLoS One       Date:  2008-07-23       Impact factor: 3.240

Review 6.  DLC-1:a Rho GTPase-activating protein and tumour suppressor.

Authors:  Marian E Durkin; Bao-Zhu Yuan; Xiaoling Zhou; Drazen B Zimonjic; Douglas R Lowy; Snorri S Thorgeirsson; Nicholas C Popescu
Journal:  J Cell Mol Med       Date:  2007 Sep-Oct       Impact factor: 5.310

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.